First-line treatment with subcutaneous epcoritamab plus R-CHOP in patients with high-risk diffuse large B-cell lymphoma (DLBCL): Phase 1/2 data update Meeting Abstract
| Authors: | Falchi, L.; Offner, F.; Belada, D.; Brody, J.; Linton, K. M.; Karimi, Y.; Cordoba, R.; Snauwaert, S.; Abbas, A.; Wang, L. W.; Wu, J.; Elliott, B.; Clausen, M. R. |
| Abstract Title: | First-line treatment with subcutaneous epcoritamab plus R-CHOP in patients with high-risk diffuse large B-cell lymphoma (DLBCL): Phase 1/2 data update |
| Meeting Title: | 10th Annual Meeting of the Society of Hematologic Oncology (SOHO) |
| Keywords: | hematologic malignancy; diffuse large b-cell lymphoma; non-hodgkin lymphoma; phase i/ii; bispecific; abcl |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 22 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2022 Sep 28-Oct 1 |
| Meeting Location: | Houston, TX |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2022-10-01 |
| Start Page: | S380 |
| Language: | English |
| ACCESSION: | WOS:000897948100421 |
| PROVIDER: | wos |
| DOI: | 10.1016/s2152-2650(22)01542-7 |
| Notes: | Meeting Abstract: ABCL-452 -- Source: Wos |
